featured
Safety and Efficacy of Mosunetuzumab Plus CHOP in Patients With Previously Untreated DLBCL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Mosunetuzumab in combination with CHOP in previously untreated DLBCL: safety and efficacy results from a phase 2 study
Blood Adv 2023 Aug 15;[EPub Ahead of Print], AJ Olszewski, TJ Phillips, MS Hoffmann, P Armand, TM Kim, DH Yoon, A Mehta, R Greil, JR Westin, IS Lossos, J Munoz, J Sit, MC Wei, A Yang, V Chen, E Purev, DL Yee, U JaegerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.